Scot Sorensen

744 total citations
10 papers, 602 citations indexed

About

Scot Sorensen is a scholar working on Pathology and Forensic Medicine, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Scot Sorensen has authored 10 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 5 papers in Genetics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Scot Sorensen's work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lung Cancer Treatments and Mutations (3 papers). Scot Sorensen is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Lung Cancer Treatments and Mutations (3 papers). Scot Sorensen collaborates with scholars based in United States, France and Cyprus. Scot Sorensen's co-authors include D F Moravec, Mark Hutchins, Jamés O. Armitage, David Howe, Monroe D. Dowling, J A Mailliard, Dennis D. Weisenburger, Julie M. Vose, Philip J. Bierman and Robert T. Eagan and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and The American Journal of Medicine.

In The Last Decade

Scot Sorensen

10 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scot Sorensen United States 9 472 260 179 169 150 10 602
D F Moravec United States 6 466 1.0× 237 0.9× 171 1.0× 143 0.8× 97 0.6× 8 516
E. Dühmke Germany 3 460 1.0× 259 1.0× 177 1.0× 113 0.7× 190 1.3× 7 553
M Bertini Italy 16 586 1.2× 379 1.5× 252 1.4× 225 1.3× 135 0.9× 44 901
J O Armitage United States 7 493 1.0× 298 1.1× 134 0.7× 214 1.3× 103 0.7× 9 609
P. Salvador United States 7 620 1.3× 386 1.5× 202 1.1× 201 1.2× 171 1.1× 7 840
Jane Myers United States 10 554 1.2× 249 1.0× 212 1.2× 138 0.8× 252 1.7× 15 614
CN Coleman United States 5 449 1.0× 177 0.7× 160 0.9× 93 0.6× 186 1.2× 7 544
Delia Rota Scalabrini Italy 11 447 0.9× 290 1.1× 188 1.1× 97 0.6× 134 0.9× 25 600
Patrizia Albertini Italy 12 576 1.2× 260 1.0× 213 1.2× 150 0.9× 140 0.9× 17 714
N. Dupouy France 10 388 0.8× 216 0.8× 141 0.8× 74 0.4× 344 2.3× 13 707

Countries citing papers authored by Scot Sorensen

Since Specialization
Citations

This map shows the geographic impact of Scot Sorensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scot Sorensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scot Sorensen more than expected).

Fields of papers citing papers by Scot Sorensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scot Sorensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scot Sorensen. The network helps show where Scot Sorensen may publish in the future.

Co-authorship network of co-authors of Scot Sorensen

This figure shows the co-authorship network connecting the top 25 collaborators of Scot Sorensen. A scholar is included among the top collaborators of Scot Sorensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scot Sorensen. Scot Sorensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bavitz, J. Bruce, et al.. (1992). Non-Hodgkin’s Lymphoma Disguised as Odontogenic Pain. The Journal of the American Dental Association. 123(3). 99–100. 11 indexed citations
2.
Vose, Julie M., P. J. Bierman, J R Anderson, et al.. (1991). CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.. Journal of Clinical Oncology. 9(8). 1421–1425. 20 indexed citations
3.
Armitage, Jamés O., Philip J. Bierman, Dennis D. Weisenburger, et al.. (1989). Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation. The American Journal of Medicine. 87(3). 285–288. 44 indexed citations
4.
Armitage, Jamés O., Julie M. Vose, J Linder, et al.. (1989). Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 7(12). 1783–1790. 76 indexed citations
5.
Vose, Julie M., DD Weisenburger, D F Moravec, et al.. (1988). Ch1VPP—An Effective and Well-Tolerated Alternative to MOPP Therapy for Hodgkinʼs Disease. American Journal of Clinical Oncology. 11(4). 423–426. 14 indexed citations
6.
Vose, Julie M., Jamés O. Armitage, Dennis D. Weisenburger, et al.. (1988). The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 6(12). 1838–1844. 225 indexed citations
7.
Armitage, Jamés O., et al.. (1988). Pulmonary Emboli in Patients Receiving Chemotherapy for Non-Hodgkin's Lymphoma. CHEST Journal. 94(3). 589–594. 6 indexed citations
8.
Armitage, Jamés O., DD Weisenburger, Mark Hutchins, et al.. (1986). Chemotherapy for diffuse large-cell lymphoma--rapidly responding patients have more durable remissions.. Journal of Clinical Oncology. 4(2). 160–164. 132 indexed citations
9.
Sorensen, Scot, et al.. (1984). Meningeal Carcinomatosis in Patients With Primary Breast or Lung Cancer. Mayo Clinic Proceedings. 59(2). 91–94. 58 indexed citations
10.
Rubin, Joseph, Scot Sorensen, Allan J. Schutt, et al.. (1983). A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma. American Journal of Clinical Oncology. 6(3). 325–326. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026